Comparison of pathologic characteristics of T1c and non-Tic cancers detected in a population-based screening study, the European randomized study of screening for prostate cancer-Reference-Cited by-同舟云学术

Comparison of pathologic characteristics of T1c and non-Tic cancers detected in a population-based screening study, the European randomized study of screening for prostate cancer

Published:1997-11 Issue:6 Volume:15 Page:339-345
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Hoedemaeker Robert F.,Rietbergen John B. W.,Kranse Ries,van der Kwast Theodorus H.,Schröder Fritz H.

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/BF01300181.pdf

Reference18 articles.

1. Abdel Aziz AE, Van Poppel HP, Van de Voorde WM, Van Dorpe JA, Oyen RH, Baert LV (1997) Impalpable invisible stage Tlc prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens - a different view. J Urol 157: 244?250

2. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J (1995) Long-term survival among men with conservatively treated localized prostate cancer. JAMA 274: 626?631

3. Auvinen A, Rietbergen JBW, Denis LJ, Schroder FH, Prorok PC (1996) Prospective evaluation plan for randomised trials of prostate cancer screening. J Med Screening 3: 97?104

4. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, Andriole GL (1991) Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324: 1156?1161

5. Catalona WJ, Smith DS, Ratliff TL, Basler JW (1993) Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270: 948?954

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes of nonpalpable prostate cancer (T1c) patients treated with radical prostatectomy;Prostate International;2015-03

2. Defining the threshold for significant versus insignificant prostate cancer;Nature Reviews Urology;2013-05-28

3. Is substaging necessary in patients with pathological stage T2 prostate cancer?;Türk Üroloji Dergisi/Turkish Journal of Urology;2011-12-01

4. Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomy;The Prostate;2011-05-02

5. A Critical Analysis of the Tumor Volume Threshold for Clinically Insignificant Prostate Cancer Using a Data Set of a Randomized Screening Trial;Journal of Urology;2011-01